Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

NCT00590694 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Age-related Macular Degeneration
Pigment Epithelial Detachment
Neovascular Macular Degeneration
Wet Macular Degeneration

Interventions

DRUG: ranibizumab

Sponsor

Pacific Eye Associates

Collaborators

[object Object]